JAMA Oncology·2026-10-08 08:00· 9 天前AI 评分26超越肿瘤大小,迈向有意义的患者结局:实体瘤疗效评价标准(RECIST)述评Beyond Tumor Size, Toward Meaningful Patient OutcomesAI 导读这篇观点文章评估实体瘤疗效评价标准(RECIST)在癌症治疗已超越细胞毒化疗的背景下,对治疗结局评价的当前适用性。讨论聚焦于超越肿瘤大小、转向有意义的患者结局这一评价方向。来源:JAMA Oncology · jamanetwork.com肿瘤解读与观点#解读/观点#肿瘤#JAMA